Camplify share price sinks 6% on growing FY22 losses

A big uptick in future booking values could bode well for the travel demand outlook in FY23.

| More on:
a woman looks exhausted and overwhelmed as she slumps forward into her hand while looking at her laptop screen.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • The Camplify share price is falling on the back of the company's FY22 results
  • Net losses increased to $8.1 million in FY22
  • Despite lingering pandemic travel restrictions, revenue increased to $16.4 million

The Camplify Holdings Ltd (ASX: CHL) share price is down 5.56% in afternoon trade, having earlier posted intraday losses of more than 13%.

Camplify shares closed yesterday at $2.52 and are currently trading for $2.38 each.

The company, which provides a peer-to-peer digital marketplace platform that connects recreational vehicle owners with hirers, released its full-year results for the 12 months ending 30 June (FY22) this morning.

Here are the highlights.

Camplify share price drops on growing losses

  • Revenue of $16.4 million, up 94% year on year
  • Net loss after tax of $8.2 million, compared to a $2.1 million loss in FY21
  • Net cash outflows of $6.1 million, compared to net cash inflows of $16.4 million in FY21
  • Total equity at 30 June of $9.4 million, down from $14.1 million the prior year

What else happened during the year?

The company noted its business was impacted by pandemic-related travel restrictions for much of the 2022 financial year.

It attributed its strong revenue growth to a 61% increase in hirer revenue and a 280% increase in van sales from FY21.

Cost of sales was up, however, increasing from $2.6 million in the prior year to $6.3 million in FY22.

Gross profit margins fell to 46%, down from 62% in the prior year. Margins were impacted by increased insurance premiums and a revenue recognition change. Camplify said its increased insurance costs will be passed on in full in FY23.

The retention rate of hirers, a key focus area for Camplify, increased to 25% during the year, up from 20% the previous year. The company also grew its customer database by some 88,000 customers.

What did management say?

Commenting on the results, Camplify CEO Justin Hales said:

Camplify is a business with significant growth potential, and substantial scalability opportunities. Camplify has delivered on its strategic outcomes in FY22 by clearly building on customer demand to record four quarters of continued growth.

As growth continues in FY23 based on customer demand, Camplify will position the business to ensure scalability, and automation will deliver improved bottom line results, on our road towards profitability.

What's next?

While not providing specific guidance, Camplify noted a big uptick in future booking values, boding well for the travel demand outlook in FY23.

As at 30 June, Camplify had $14.7 million in future bookings, compared to $7.0 million in FY21. The company stated, "This over doubling of future bookings clearly demonstrates from customers their intention to travel in FY23."

Camplify share price snapshot

It's been a difficult year for the Camplify share price, down 42% since the opening bell on 4 January. By comparison, the All Ordinaries Index (ASX: XAO) is down 8% year-to-date.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Camplify Holdings Limited. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Earnings Results

A female financial services professional with a manicured black afro hairstyle turns an ipad screen to show a client across the table a set of ASX shares figures in graph format.
Earnings Results

Macquarie shares slump 7% on half-year earnings miss

Let's see how the investment bank performed during the first half.

Read more »

two men raise their fists and shout with their mouths wide open on a sofa as though they are watching sport or something stirring on a television that is out of picture.
Earnings Results

Nine Entertainment flags digital growth and more cost cuts in FY26 update

Nine Entertainment has reported upbeat digital subscription growth and expects further EBITDA gains, despite a tough ad market in FY26.

Read more »

A woman wearing a hat, sunglasses and a bathing suit reads the newspaper while sitting on a lounging chair that's placed in a pool in a relaxing setting.
Earnings Results

News Corporation Q1 FY26: Digital-led growth, higher buybacks

News Corporation lifted Q1 FY26 revenue and EBITDA, fuelled by digital growth and a strong performance from Dow Jones.

Read more »

A typical Australian family of mother, father, and two kids stands outside their modest but homely Australian suburban home complete with green grass, outdoor plants and furniture.
Earnings Results

REA Group share price on watch after Q1 FY26 results show growth in revenue and yield

REA Group delivered Q1 FY26 revenue growth and record audience, as its share price responds to the latest earnings results.

Read more »

Happy shareholders clap and smile as they listen to a company earnings report.
Earnings Results

Macquarie Group posts higher 1H26 profit and ups dividend

Macquarie Group delivered higher first-half profit and revenue, declared an interim dividend, and flagged cautious optimism amid mixed conditions.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Earnings Results

Neuren Pharmaceuticals Q3 2025: Record DAYBUE sales fuel robust growth

Neuren Pharmaceuticals reported record DAYBUE sales and royalties in Q3 2025, with expanding US and international demand.

Read more »

Management presents the ASX company earnings report to shareholders at an AGM.
Earnings Results

Vicinity Centres FY25 earnings: profit doubles, outlook upbeat

Vicinity Centres reported $1 billion statutory profit for FY25, rising distributions, and a positive outlook for FY26.

Read more »

Happy couple at Bank ATM machine.
Bank Shares

NAB shares fall on FY25 profit miss

Let's see how the banking giant performed during the financial year.

Read more »